Skip to main content
The BMJ logoLink to The BMJ
. 2008 May 10;336(7652):1046–1048. doi: 10.1136/bmj.39541.470023.AD

Autonomy, stress, and treatment of depression

Paul Biegler 1,2,3,
PMCID: PMC2376029  PMID: 18467412

Abstract

Psychotherapy canhelp patients understand the triggers for depression and how to deal with them. Paul Biegler argues that these effects should be given moral weight when deciding on treatment


Most guidelines on the treatment of less severe forms of depression conclude that antidepressants and psychotherapy have similar efficacy and recommend that either can be used.1 2 The evidence for these recommendations derives from studies that measure reduction of symptoms on instruments such as the Hamilton rating scale. However, these studies fail to take into account the role of self knowledge in the success of evidence based psychotherapy and the potential importance it has for depressed people. Psychotherapy affords people with depression greater autonomy in decisions and actions that relate to the object, or trigger, of the depressed response. Patient autonomy is rightly given considerable weight in medicine, and it should have greater influence on the discussions that guide treatment in depression.

Depression as a response to stressors

Some years ago, the philosopher and physician Carl Elliot wondered what might be wrong with using antidepressants to treat a melancholy Sisyphus, sentenced in perpetuity to pushing a big rock up a steep hill, only to see it roll back down again. Elliot concluded that to modify the affective response of Sisyphus with a drug was to ignore “certain larger aspects of his predicament connected to boulders, mountains, and eternity.”3 Elliot’s concerns—that the use of antidepressants fails to deal with the context in which the depression occurs—are given impetus by data showing that nearly 70% of depressive episodes are triggered by psychosocial stressors.4 Moreover, it is increasingly likely that many of the changes in brain chemistry that feature in depression, and that are targeted by antidepressants, follow from increased production of cortisol in response to stress.5

It is acknowledged that genetic predisposition6 and individual vulnerability stemming from adversity in early life7 predict a depressed response to stressors. And there is some evidence for a kindling effect, whereby stressors provoke depression at ever lower thresholds as the number of episodes mounts.8 Also, melancholic depression can occur independently of the effect of stressors, although it is uncommon.9 However, it remains the case that stressful life events are a common causal antecedent to many depressive episodes, a fact that has strong bearing on personal autonomy.

Personal autonomy

Through autonomous decisions individuals are well placed to act in accordance with deeply held values and goals that form part of an overarching life plan.10 The information that is important for, or material to, such decisions is that with relevance for the person’s significant interests.11 To use an example from the informed consent model, the small functional improvement that results from surgery for a minor fracture of the finger is likely to be material to a concert pianist but not to a professional boxer.

Information about the relation between stressors and depression is likely to be material to depressed people, hence understanding it promotes the autonomy with which the person decides, and acts, in relation to a stressful event. Appraisal theory, which holds that negative affect arises when important goals and interests are threatened, supports this.12 Consider the despondency that often follows, for example, a broken engagement, the loss of a job, or failure in an examination. Depression, although a pathological sadness, can, in many cases, be thought of as an appraisal signifying loss, disappointment, and thwarted ambitions. If depression is viewed as a marker of a threat to interests, there is good reason to see information pertaining to its trigger as material to the depressed person.

Material facts in depression

Three facets of the stressor-depression relation are strong candidates to comprise material information for depressed people. Firstly, it is likely to be pertinent that stressors can bring on the disorder. If data from the general population can be used as a guide, around a third of people with depression may fail to recognise this fact.13 Just as most would agree that people with asthma ought to be apprised of the deleterious effects of cigarette smoke, so too should people with depression know of the aetiological role of stressors. This information affords a further option for dealing with the illness.

Secondly, it is important for depressed people to appreciate how stressful events precipitate depression. Evidence supports a pivotal role for biases that favour the processing of negative information.14 These biases lead to unrealistic pessimism about the outcome of stressful events as well as excessive self attribution of their cause. In depression, false negative thoughts are commonly taken at face value and guide the person’s subsequent behaviour. Given that such behaviour is mostly self defeating, and that a more accurate way of dealing with negative thoughts can be learnt, insight into the action of negative biases is also likely to be material to the depressed person.

Of course, some circumstances are so grievous that a depressed response can seem warranted. The concept of “depressive realism” takes this observation further in proposing that the predictions of those with depression are in fact more accurate than those of their non-depressed counterparts.15 However, although extreme sadness is sometimes appropriate, depressive realism is contested,16 and the evidence remains strong that depressed perceptions are mostly unreliable14 and become even less reliable as depression worsens.17

Finally, people with depression will be concerned to know what can be done to help them deal better with stressful life events. Underpinning this contention is the recognition of depression as a maladaptive reaction to taxing circumstances.18 People whose initial response to relationship, financial, or work difficulties is one that heightens the likelihood of subsequent depression, place in jeopardy the compelling interests that are tied to each pursuit. Thus, knowledge that a more adaptive response to these kinds of hurdles can be mastered is likely to be material.

Psychotherapy and autonomy

Psychotherapies that have been shown to be effective in depression promote understanding of all three facets of the stressor-depression relation. For example, cognitive behavioural therapy and interpersonal therapy, while containing more generic elements, seek to locate a depressive episode within the context of an onerous situation. Cognitive behavioural therapy also uses “debiasing” strategies that challenge negative thinking. In addition, the therapies contain problem-focused elements that seek to elucidate depressive triggers and to assist coping responses to them. Indeed, problem solving therapy alone has shown promise as a treatment for depression.19

The effects of psychosocial stressors are critical for the depressed individual’s interests. It follows that an understanding of those effects through psychotherapy promotes the autonomy with which the depressed person decides, and acts, in relation to stressful events.

Antidepressants and autonomy

There is little question that antidepressants can also promote autonomy in depression. Sometimes the paralysing torpor of depression can be lifted only with drugs. Antidepressants are life saving in many cases and are the treatment of choice in most categories of severe depression. Moreover, recent work suggests that selective serotonin and noradrenaline reuptake inhibitors have a neuropsychological mode of action that shares much with that of the evidence based psychotherapies.20 These drugs seem to increase attention to positive information and, through that, may counter the negative biases that mediate depressed thinking.

However, medication alone does not afford the kinds of insight that, I argue, are material to people with depression. Depression recurs in up to 80% of sufferers21 so, as a recent commentator has highlighted,22 in most cases ought to be managed as a chronic illness. Successful psychotherapy enables depressed people to make more accurate appraisals during future stressful events, providing a credible autonomy advantage.

Beneficence and autonomy

If psychotherapy affords greater personal autonomy then it might be argued that it is the better treatment for depression and doctors should be required to provide it under their duty of beneficence. But this is valid only if autonomy is viewed as primarily of instrumental value in furthering the individual’s interests. The importance for wellbeing of acting from informed and rational preferences is widely acknowledged, and the autonomous individual is well placed to express such preferences.23

However, autonomy also has intrinsic value, independent of the benefits or burdens that might flow from the exercise of autonomous choice. For example, respect for the autonomous wishes of someone who continues to smoke, despite an appreciation that such a choice is detrimental to health, stems from the value accorded a basic right to decide on issues of subjective importance. Accordingly, the depressed person who deals more autonomously with stressors may be better off, but is not necessarily so. For this reason a therapy that better promotes autonomy cannot simply be relabelled as one that is more beneficent.

Implications for clinical practice

What do the above arguments mean for doctors treating patients with depression? All else being equal, and mindful of the importance already accorded patient autonomy in medicine, they provide strong additional reason to recommend psychotherapy for depressed patients. In fact, doctors who profess to take autonomy seriously are perhaps obliged to support this course of action.

But all else is often not equal when it comes to managing depression. For a start, the patient might show traits that make it likely that one or other treatment, or a combination, will be more effective. Alternatively, the patient might make a considered decision in favour of antidepressants and so a case could be made, on beneficence grounds, that antidepressants are the treatment of choice. Psychotherapy might be untenable because it is unavailable, too expensive, or cannot be delivered in a timely fashion. Or the doctor might be sceptical of the benefits of psychotherapy, believing its effects derive largely from the therapeutic alliance that it forges,24 or that its efficacy in controlled trials translates poorly to effectiveness in the clinical setting.25 Conversely, emerging evidence of better prevention of relapse with cognitive behavioural therapy could lead to it being considered more favourably on the grounds of efficacy alone.26

Although these concerns will drive treatment choice in some situations, for many patients both antidepressants and psychotherapy are available and effective options. In these instances, the argument presented suggests doctors should place considerable weight on the autonomy promoting effects of evidence based psychotherapy when discussing treatment with depressed patients. It also points to an ethical dimension that is worthy of greater attention in the ongoing debate on how best to tackle the formidable challenges posed by depression.

Summary points

  • Studies show antidepressants and psychotherapy have comparable efficacy in less severe grades of depression

  • Standard efficacy criteria do not measure the self knowledge that comes from successful psychotherapy

  • Self knowledge promotes autonomy in dealing with stressful life events

  • Personal autonomy provides strong additional reason to recommend psychotherapy in depression

Contributors and sources: PB is an Australian bioethicist and emergency physician. He has a strong interest in psychological medicine, recently completing a PhD at Monash University’s School of Philosophy and Bioethics, which examined ethical issues in the treatment of depression. This article derives from work completed as part of his doctoral dissertation.

Funding: This research was generously supported by a Monash postgraduate scholarship and a Monash arts postgraduate publications award. PB’s employer, Bayside Health, provided sabbatical leave to allow preparation of this article.

Competing interests: None declared.

Provenance and peer review: Not commissioned; externally peer reviewed.

References

  • 1.National Institute for Clinical Excellence. Depression: management of depression in primary and secondary care London: NICE, 2004.
  • 2.Ellis P. Australian and New Zealand clinical practice guidelines for the treatment of depression. Aust N Z J Psychiatry 2004;38:389-407. [DOI] [PubMed] [Google Scholar]
  • 3.Elliott C. Better than well: American medicine meets the American dream New York: W W Norton, 2003:260.
  • 4.Kendler KS, Karkowski LM, Prescott CA. Causal relationship between stressful life events and the onset of major depression. Am J Psychiatry 1999;156:837-41. [DOI] [PubMed] [Google Scholar]
  • 5.Van Praag HM. Can stress cause depression? Prog Neuropsychopharmacol Biol Psychiatry 2004;28:891-907. [DOI] [PubMed] [Google Scholar]
  • 6.Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003;301:386-9. [DOI] [PubMed] [Google Scholar]
  • 7.Kendler KS, Gardner CO, Prescott CA. Toward a comprehensive developmental model for major depression in men. Am J Psychiatry 2006;163:115-24. [DOI] [PubMed] [Google Scholar]
  • 8.Kendler KS, Thornton LM, Gardner CO. Stressful life events and previous episodes in the etiology of major depression in women: an evaluation of the “kindling” hypothesis. Am J Psychiatry 2000;157:1243-51. [DOI] [PubMed] [Google Scholar]
  • 9.Mitchell PB, Parker GB, Gladstone GL, Wilhelm K, Austin MP. Severity of stressful life events in first and subsequent episodes of depression: the relevance of depressive subtype. J Affect Disord 2003;73:245-52. [DOI] [PubMed] [Google Scholar]
  • 10.Young R. Personal autonomy: beyond negative and positive liberty London: Croom Helm, 1986
  • 11.Faden RR, Beauchamp TL, King NMP. A history and theory of informed consent New York: Oxford University Press, 1986
  • 12.Lazarus RS. Appraisal: the long and the short of it. In: Eckman P, Davidson RJ, eds. The nature of emotion: fundamental questions New York: Oxford University Press, 1994:208-15.
  • 13.Matschinger H, Angermeyer MC. Lay beliefs about the causes of mental disorders: a new methodological approach. Soc Psychiatry Psychiatr Epidemiol 1996;31:309-15. [DOI] [PubMed] [Google Scholar]
  • 14.Macleod A, Tata P, Kentish J, Carroll F, Hunter E. Anxiety, depression, and explanation-based pessimism for future positive and negative events. Clin Psychol Psychother 1997;4:15-24. [Google Scholar]
  • 15.Alloy LB, Abramson LY. Judgment of contingency in depressed and nondepressed students: sadder but wiser? J Exp Psychol Gen 1979;108:441-85. [DOI] [PubMed] [Google Scholar]
  • 16.Fu T, Koutstaal W, Fu CHY, Poon L, Cleare AJ. Depression, confidence and decision: evidence against depressive realism. J Psychopathol Behav Assess 2005;27:243-52. [Google Scholar]
  • 17.Andersen SM, Spielman LA, Bargh JA. Future-event schemas and certainty about the future: automaticity in the depressive’s future event predictions. J Pers Soc Psychol 2002;63:711-23. [DOI] [PubMed] [Google Scholar]
  • 18.Lazarus RS, Folkman S. Stress, appraisal, and coping New York: Springer, 1984
  • 19.Mynors-Wallis LM, Gath DH, Day A, Baker F. Randomised controlled trial of problem solving treatment, antidepressant medication, and combined treatment for major depression in primary care. BMJ 2000;320:26-30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Harmer CJ, Shelley NC, Cowen PJ, Goodwin GM. Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition. Am J Psychiatry 2004;161:1256-63. [DOI] [PubMed] [Google Scholar]
  • 21.Nierenberg AA, Alpert JE. Depressive breakthrough. Psychiatr Clin North Am 2000;23:731-42. [DOI] [PubMed] [Google Scholar]
  • 22.Scott J. Depression should be managed like a chronic disease. BMJ 2006;332:985-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Griffin J. Well-being: its meaning, measurement, and moral importance Oxford: Clarendon Press, 1986
  • 24.Dimidjian S, Dobson KS. Processes of change in cognitive therapy. In: Reinecke MA, Clarke DA, eds. Cognitive therapy across the lifespan: evidence and practice Cambridge: Cambridge University Press, 2004:477-506.
  • 25.Holmes J. All you need is cognitive behaviour therapy? BMJ 2002;324:288-90. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Hollon SD, DeRubeis RJ, Shelton RC, Amsterdam JD, Salomon RM, O’Reardon JP, et al. Prevention of relapse following cognitive therapy vs medications in moderate to severe depression. Arch Gen Psychiatry 2005;62:417-22. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES